Search Clinical Trials
Completed
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension (External Link)
PROTOCOL OUTLINE: Patients are treated with a chronic continuous infusion of epoprostenol. The highest tolerated infusion rate is determined for each patient by gradually increasing the rate until the target …
Baylor Role:
Collaborator